NDC 0597-0197 – Praxbind

Idarucizumab 50 mg/mL · Injection · Intravenous

Human Prescription Drug

Product NDC0597-0197

Product details

Brand name
Praxbind
Generic name
Idarucizumab
Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Dosage form
Injection
Route
Intravenous
Marketing category
BLA · BLA761025
Marketed since
October 21, 2015
Listing expires
December 31, 2026
Pharmacologic class
Humanized Monoclonal Antibody Fragment

Active ingredients

Uses, dosage, side effects and warnings for Praxbind →

Package NDC codes (1)

Package NDCDescriptionSince
0597-0197-052 VIAL, SINGLE-DOSE in 1 CARTON (0597-0197-05) / 50 mL in 1 VIAL, SINGLE-DOSEOct 21, 2015